FDA Labels - Search News

FDA, GLP-1 and suicidal thoughts

· 9h · on MSN

US FDA requests removal of suicide warnings from weight-loss drug labels

The U.S. health regulator asked drugmakers on Tuesday to remove warnings about a potential risk of suicidal thoughts from widely used GLP-1 weight-loss drugs, including Novo Nordisk's Wegovy and Eli Lilly's Zepbound.

Continue reading

MedPage Today on MSN · 9h

FDA Says to Drop Suicide Warning From GLP-1 Drug Labels

Axios on MSN · 13h

FDA calls on GLP-1 drugmakers to remove suicide warnings

The Cardiology Advisor

FDA May Reduce How Often Supplement Warnings Appear on Labels

The FDA is weighing a change that could make warning labels on dietary supplements appear less often on packaging.

2mon

FDA removes the black box warning on hormone therapy for menopause

Hormone therapy helps women. Now the FDA is reversing its warning on estrogen treatment which could change treatemtn for ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results